Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
mi
from
El Paso, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
El Paso, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
mi
from
Galveston, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Galveston, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
mi
from
Houston, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
mi
from
Mesquite, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Mesquite, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
mi
from
Nassau Bay, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Nassau Bay, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
mi
from
San Antonio, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
mi
from
Sugar Land, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Sugar Land, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
mi
from
Tomball, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Tomball, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
mi
from
Webster, TX
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Webster, TX
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
mi
from
Chesapeake, VA
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Chesapeake, VA
Click here to add this to my saved trials
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated:  3/20/2018
mi
from
Ostrava,
A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis (RADIANCE)
A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade® (Infliximab) for the Treatment of Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 3/20/2018
Nichi-Iko Investigational Site
mi
from
Ostrava,
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Indianapolis, IN
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Brooklyn, NY
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Birmingham, AL
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Paradise Valley, AZ
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Paradise Valley, AZ
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Peoria, AZ
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Phoenix, AZ
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Scottsdale, AZ
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Tucson, AZ
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Hot Springs, AR
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Hot Springs, AR
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Little Rock, AR
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
San Diego, CA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Torrance, CA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Tustin, CA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Whittier, CA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Whittier, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Wildomar, CA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Wildomar, CA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Colorado Springs, CO
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Lewes, DE
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Lewes, DE
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Aventura, FL
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Aventura, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Debary, FL
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Debary, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Palm Harbor, FL
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Pinellas Park, FL
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Saint Petersburg, FL
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Tamarac, FL
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Tamarac, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Venice, FL
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Venice, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Zephyrhills, FL
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Decatur, GA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Gainesville, GA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Gainesville, GA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Lawrenceville, GA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Marietta, GA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Savannah, GA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Eagle, ID
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Eagle, ID
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Morton Grove, IL
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Morton Grove, IL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Rockford, IL
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Rockford, IL
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Wichita, KA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Cumberland, MD
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Cumberland, MD
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Hyannis, MA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Hyannis, MA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Worcester, MA
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Bingham Farms, MI
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated:  3/24/2018
mi
from
Saint Clair Shores, MI
A Rheumatoid Arthritis Study in Participants
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Saint Clair Shores, MI
Click here to add this to my saved trials